Global leader in cellular imaging and analysis unveils new software
and hardware features for improved life science and drug discovery
research productivity
WALTHAM, Mass.--(BUSINESS WIRE)--
PerkinElmer,
Inc., a global leader focused on improving the health and safety of
people and the environment, today announced several new hardware and
software features for the Company's flagship Opera®
High Content Screening (HCS) System to enhance its live cell imaging and
analysis capabilities.
The enhancements to the Opera system will enable biopharmaceutical and
academic researchers to perform improved live cell imaging assays, for
more efficient drug discovery and life science research workflow.
The new features increase ease of use of the Opera system's Acapella®
High Content Imaging and Analysis Software, which now includes
assay-centric building blocks to significantly increase productivity
through an intuitive software interface. This expands the availability
of advanced high content screening and analysis to a wider user base,
allowing richer and more relevant data to be accessible earlier in the
process.
The Opera system's new transmitted light module with digital
phase-contrast will enable users to image and segment cells that have
not been labeled fluorescently. This feature is especially useful for
live cell applications as it eliminates the need to label cells, thus
diminishing potential labeling artifacts, cell damage, assay costs and
time.
"We understand the importance of making our high performance systems
even easier to use in order to continue to improve our customers'
research workflow," said Jacob Tesdorpf, director of high content
instruments and applications, PerkinElmer. "The new Opera user interface
is designed to enable more scientists than ever before to benefit from
this intuitive and powerful system. Now end-users can perform even the
most challenging imaging assay applications with live cells, for more
scientifically- and drug discovery-relevant applications."
PerkinElmer's PhenoLOGIC™
machine-learning technology is now available for the Acapella software,
and will enable Acapella software users to classify different cell
populations or regions by simple point-and-click operations. In
addition, a new 4X objective lens will enable users to quickly scan
entire wells from which they can choose an area to examine in more
detail.
About PerkinElmer, Inc.
PerkinElmer, Inc. is a global leader focused on improving the health and
safety of people and the environment. The Company reported revenue of
approximately $1.7 billion in 2010, has about 6,200 employees serving
customers in more than 150 countries, and is a component of the S&P 500
Index. Additional information is available through 1-877-PKI-NYSE, or at www.perkinelmer.com.
PerkinElmer, Inc.
Mario Fante, 781-663-5602
mario.fante@perkinelmer.com
or
Edelman
(on behalf of PerkinElmer, Inc.)
Amanda L. Connolly, 404-832-6785
amanda.connolly@edelman.com
Source: PerkinElmer, Inc.
News Provided by Acquire Media